Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study

J Infect Chemother. 2014 May;20(5):293-7. doi: 10.1016/j.jiac.2013.11.007. Epub 2014 Apr 3.

Abstract

Carbapenem-resistant Klebsiella pneumoniae (CRKP) is increasingly reported worldwide. The aim of the present study was to identify risk factors associated with the development of CRKP infections. A retrospective, case-case-control study was performed at the University Hospital of Heraklion, Greece. The study population included 83 patients from whom CRKP was isolated, 79 from whom carbapenem-sensitive K. pneumoniae (CSKP) was isolated and 161 (control group) from whom K. pneumoniae was not isolated. The median age of CRKP and CSKP patients was 79 (28-101) and 80 (39-97) years, respectively, while that of the controls was 75 (18-100) years. K. pneumoniae was isolated predominantly from urine in both case groups, followed by blood. Independent risk factors for CRKP infection/colonization were admission to ICU (p = 0.004), prior surgical procedure (p = 0.036) and presence of renal disease (p = 0.037), while for CSKP were neurological disease (p = 0.007), and older age (p = 0.011). No association between CRKP and prior antimicrobial exposure was found. Of the entire cohort 40 patients (12%) died; 22 (27%) in the CRKP, 12 (15%) in the CSKP and 6 (4%) in the control group. Isolation of any K. pneumoniae strain was associated with higher mortality compared to the control group (21% vs. 4%; p < 0.005). Mortality was not statistically different between those infected/colonized/with a CRKP or a CSKP strain (p = 0.084). According to these results prior ICU stay, prior surgical procedure and renal disease were independent risk factors for the development of a CRKP infection/colonization.

Keywords: Antimicrobial resistance; Carbapenem-resistant Klebsiella pneumoniae; Intensive care unit; Renal disease.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carbapenems / therapeutic use*
  • Case-Control Studies
  • Drug Resistance, Bacterial
  • Female
  • Humans
  • Klebsiella Infections / drug therapy*
  • Klebsiella pneumoniae / drug effects*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors

Substances

  • Carbapenems